Public Policy
Homeward's Amar Kendale, former chief product officer at Livongo and Teladoc, discusses how the industry must combine technology and new care models to improve access and make value-based payment successful.
A federal jury found three former executives guilty of defrauding investors and clients, largely pharma companies.
The company's Auto B-line Counter product uses AI to help providers assess abnormal lung conditions.
The AI-powered app allows for remote monitoring of common Parkinson's disease symptoms such as bradykinesia, tremor and dyskinesia via an Apple Watch.
In a letter, the senator urged the agency to scrutinize the acquisition and others like it, arguing the deal could increase costs and lower quality of care.
Christopher Lis, managing director of global healthcare intelligence at J.D. Power, discusses the recent primary care deals by Amazon and CVS Health.
Tyto Insights for Wheeze Detection analyzes lung sounds for possible wheezing in adults and children 2 and older.
Ajayi discusses the challenges Medicaid and other underserved patients face when accessing the healthcare system and how the startup approaches expansion into new markets.
Scott Loughlin, partner at Hogan Lovells, discusses the Federal Trade Commission's recent enforcement action against GoodRx and what digital health companies should learn from the case.
In a proposed order, the online therapy company would also pay $7.8 million for allegedly sharing consumer data with third parties like Facebook and Snapchat for advertising purposes.